These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6991154

  • 1. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter JD.
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract] [Full Text] [Related]

  • 2. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
    Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC.
    J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
    Biglieri EG, Brust N, Chang B, Hirai J, Wajchenberg BL, Schambelan M.
    Prog Biochem Pharmacol; 1980 Sep; 17():36-43. PubMed ID: 6259660
    [Abstract] [Full Text] [Related]

  • 4. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
    McCormick SD, Regish A, O'Dea MF, Shrimpton JM.
    Gen Comp Endocrinol; 2008 May 15; 157(1):35-40. PubMed ID: 18462736
    [Abstract] [Full Text] [Related]

  • 5. Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.
    Higgins JR, Wambach G, Kem DC, Gomez-Sanchez C, Holland OB, Kaplan NM.
    J Lab Clin Med; 1977 Feb 15; 89(2):250-6. PubMed ID: 137938
    [Abstract] [Full Text] [Related]

  • 6. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T, Fujimaki M, Senba S, Saito I, Konishi K.
    J Lab Clin Med; 1984 Jun 15; 103(6):848-53. PubMed ID: 6373989
    [Abstract] [Full Text] [Related]

  • 7. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG, Kater CE, Brust N, Chang B, Hirai J.
    Clin Exp Hypertens A; 1982 Jun 15; 4(9-10):1677-83. PubMed ID: 7139973
    [Abstract] [Full Text] [Related]

  • 8. Mineralocorticoids in the nephrotic syndrome of children.
    Ammenti A, Müller-Wiefel DE, Schärer K, Vecsei P.
    Clin Nephrol; 1980 Nov 15; 14(5):238-45. PubMed ID: 7014053
    [Abstract] [Full Text] [Related]

  • 9. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep 15; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 10. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
    Nakamura T, Ichikawa S, Sakamaki T, Sato K, Kogure M, Tajima Y, Kato T, Murata K.
    Proc Soc Exp Biol Med; 1987 Sep 15; 185(4):448-54. PubMed ID: 2956609
    [Abstract] [Full Text] [Related]

  • 11. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug 15; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 12. [Monogenic hypertension].
    Bähr V, Oelkers W, Diederich S.
    Med Klin (Munich); 2003 Apr 15; 98(4):208-17. PubMed ID: 12715144
    [Abstract] [Full Text] [Related]

  • 13. Stimulation and suppression of the mineralocorticoid hormones in normal subjects and adrenocortical disorders.
    Kater CE, Biglieri EG, Brust N, Chang B, Hirai J, Irony I.
    Endocr Rev; 1989 May 15; 10(2):149-64. PubMed ID: 2666117
    [Abstract] [Full Text] [Related]

  • 14. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors.
    Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC.
    Clin Sci Mol Med Suppl; 1976 Dec 15; 3():321s-324s. PubMed ID: 1071637
    [Abstract] [Full Text] [Related]

  • 15. [The effect of cortisol infusion on plasma renin activity, aldosterone levels and 11-deoxycorticosterone levels in humans (author's transl)].
    Sugawara T.
    Nihon Naibunpi Gakkai Zasshi; 1978 May 20; 54(5):710-8. PubMed ID: 689214
    [No Abstract] [Full Text] [Related]

  • 16. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE, Montero J, Mosso L.
    Rev Med Chil; 1999 May 20; 127(5):604-10. PubMed ID: 10451632
    [Abstract] [Full Text] [Related]

  • 17. Levels of mineralocorticoids in whites and blacks.
    Pratt JH, Rebhun JF, Zhou L, Ambrosius WT, Newman SA, Gomez-Sanchez CE, Mayes DF.
    Hypertension; 1999 Aug 20; 34(2):315-9. PubMed ID: 10454460
    [Abstract] [Full Text] [Related]

  • 18. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
    Chamontin B, Blanchouin-Emeric N, Amar J, Khatibi F, Vernier I, Bennet A, Aupetit-Faisant B, Salvador M.
    Arch Mal Coeur Vaiss; 1996 Aug 20; 89(8):1055-8. PubMed ID: 8949378
    [Abstract] [Full Text] [Related]

  • 19. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K, Gregorová I, Tomsová Z, Vancura J, Silinková-Málková E.
    Sb Lek; 1977 Jan 20; 79(1):1-10. PubMed ID: 841259
    [No Abstract] [Full Text] [Related]

  • 20. Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
    Haruyama K, Yamazaki M, Toki T, Fukuchi S.
    Jpn Circ J; 1982 Feb 20; 46(2):156-61. PubMed ID: 6276583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.